- Economy Shifts, and the Ethanol Industry Reels
- Services Sector Shrinks Sharply in October
- GMAC Has $2.52 Billion Loss; ResCap Survival at Risk
- Short-Dated Bonds Ease on Auction Concerns
- United Tech '08 Profit May Fall to Low End of Forecast
- Euro Rate Expected to Be Slashed by Half a Point
- Bank of England Could Keep Cutting to 0%
- Private Sector Cuts Jobs; Planned Layoffs Jump
- Marsh & McLennan Posts Third-Quarter Net Loss
- Go Bananas on Fruit Companies: Strategist
- It's All Over But the T-Shirts
- And So It Goes ...
- Valliere: Can Obama Permanently Jump-start Confidence?
- At McCain Headquarters -- Johnny Cash!
- Time to Move to the Lawn
- Obama Appears and ... Nothing
- Lightning Round: Cisco, Morgan Stanley, Bristol-Myers and More
- Cramer's Outrage: The U.S. Treasury
- AK Steel to levy surcharge, effective in December
- US Cellular 3Q profit up on higher data revenue
- Devon Energy 3Q profit more than triples
- Hawaiian Telcom postpones $26M interest payment
- NJ voters split on statewide ballot questions
- Sara Lee shares tumble on lowered 2009 outlook
- Interstate Hotels & Resorts swings to 3Q loss
- GlaxoSmithKline trimming US sales force by 1,000
- Harsco gets $220 million credit facility
- Mo. voters approve 5 statewide issues
CLARENCE, N.Y. - Medical components maker Greatbatch Inc. said Tuesday its profit rose 53 percent in the third quarter, as the company gained revenue from the seven businesses it bought in 2008.
For the three months ended Sept. 26, Greatbatch reported a profit of $7.6 million, or 33 cents per share. That is up from $5 million, or 22 cents per share a year earlier. Excluding integration costs from the buyouts and other one-time expenses, the company said it earned 44 cents per share.
Revenue jumped 72 percent, to $136.2 million from $79 million, largely due to the newly acquired orthopedics business.
Analysts expected a profit of 32 cents per share on $128.4 million in revenue, according to Thomson Reuters.
Greatbatch company has made an effort to diversify its products and move into new markets. It said sales of implantable medical components surged 75 percent, to $117.3 million. That included $37.9 million in orthopedic revenue, a new business. Neuromodulation revenue grew 14 percent to $64.9 million, and therapy delivery revenue increased 45 percent to $14.5 million.
Sales of electrochemical devices rose 58 percent to $18.9 million.
Greatbatch backed its full-year forecasts of $1.20 to $1.50 per share in profit and $490 million to $530 million in revenue. Analysts expect an average profit of $1.19 per share and revenue of $523.9 million.


